Registered Nurse in Clearwater, FL Accepting Medicare
86 Registered Nurse nurses found. Showing 81 - 86
 Steve Young, RN Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 380 Park Place Blvd, Suite 150, Clearwater, FL 33759 Phone: 727-726-6669 Fax: 727-726-0688 |
 Lavett Jackson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2188 58th St N, Clearwater, FL 33760 Phone: 727-327-7656 Fax: 727-322-2142 |
Ann Rudolph Owen, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1700 N Mcmullen Booth Rd Ste C3, Clearwater, FL 33759 Phone: 727-669-4551 Fax: 727-669-2420 |
Linda Ann Selker, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 455 Pinellas Street, Suite 400, Clearwater, FL 33756 Phone: 727-445-1911 Fax: 727-445-1911 |
Lauren Alter, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-462-7000 |
Okiemute Parra, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 694 Canterbury Rd, Clearwater, FL 33764 Phone: 727-460-2123 |
News Archive
Immune ‘hotspots' could help predict the risk of breast cancer relapse in patients, study finds
Scientists from The Institute of Cancer Research, London has developed a new test through which women at a greater risk of relapsing from breast cancer within 10 years of diagnosis can be identified.
CSIS hosts public launch of USAID Global Health Strategy
The Center for Strategic & International Studies (CSIS) on Monday "hosted the public launch of the new USAID Global Health Strategy to support implementation of the Global Health Initiative," according to its website.
Second Sight's Argus II Retinal Prosthesis System scheduled for FDA panel review
Second Sight Medical Products Inc., the world's leading developer and manufacturer of retinal prostheses, today announced that a U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel has been scheduled to review the data presented in the company's Humanitarian Device Exemption (HDE) market approval application for its Argus II Retinal Prosthesis System (Argus II prosthesis) on September 28, 2012 in Gaithersburg, Maryland.
Rigel first quarter net loss increases to $23.2 million
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2012.
Starting university may be hazardous to your health
Moving away from home and adapting to a new social environment are just two of the many challenges that new students face as they enter university.
› Verified 5 days ago
Nurse Practitioner
Physician Assistant
Nurse Anesthetist - CR
Registered Nurse